To overcome this issue, Neal et al. proposed a co-cultured system of cancer organoids and endogenous tumor infiltrating lymphocytes to test the drug response of anti-PD-1 or anti-PD-L1 immune check point inhibitors [33]. The gene discussed is CD274; the disease is cancer.